2026-10-19T01:56:10Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/202872026-10-18T21:12:07Zopenairedrivercom_ebyu_10000col_ebyu_10001

Contrast-Induced Nephropathy: Management by Antioxidant TherapyTOPAL, ErgünCEYHUN, GökhanBuyuklu, MutluDeğirmenci, HüsnüBAKIRCI, EFTAL MURATGenel ve Dahili TıpÜroloji ve NefrolojiAt present, the number of imaging and interventional procedures using contrast agents is gradually increasing. Oxidative stress plays a significant role in its pathophysiology. Despite the use of various prophylactic therapies and low-osmolar contrast agents with lesser adverse effects, intravenous isotonic fluid infusion is the only method that has been proven to be effective in preventing contrast-induced nephropathy in clinic practice. Therefore, a novel kidney-protecting treatment model is required for contrast-induced nephropathy.2017Review Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/20287trKoşuyolu Heart Journalinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/reviewhttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/20287